Genus plc (LON:GNS – Get Free Report)’s share price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 1,822.91 ($23.52) and traded as high as GBX 1,862 ($24.02). Genus shares last traded at GBX 1,818.34 ($23.46), with a volume of 167,569 shares trading hands.
Wall Street Analyst Weigh In
Separately, Shore Capital reaffirmed a “buy” rating on shares of Genus in a research note on Wednesday, December 11th.
Check Out Our Latest Stock Analysis on GNS
Genus Price Performance
Genus (LON:GNS – Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported GBX 39.80 ($0.51) earnings per share for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. On average, equities research analysts forecast that Genus plc will post 70.9644323 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Genus news, insider Jorgen Kokke sold 19,967 shares of Genus stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of GBX 1,731 ($22.33), for a total transaction of £345,628.77 ($445,857.55). 0.75% of the stock is currently owned by company insiders.
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Read More
- Five stocks we like better than Genus
- What Are Dividend Champions? How to Invest in the Champions
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What is diluted earnings per share (Diluted EPS)?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Quiet Period Expirations Explained
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.